{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:07:35Z","timestamp":1792591655166,"version":"4.5.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00322","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:43:26Z","timestamp":1558687406000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Clinical Use of FSH in Male Infertility"],"prefix":"10.3389","volume":"10","author":[{"given":"Hermann M.","family":"Behre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fendo.2018.00763","article-title":"Role of follicle-stimulating hormone in spermatogenesis","volume":"9","author":"Oduwole","year":"2018","journal-title":"Front Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s40618-018-0843-y","article-title":"The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS)","volume":"41","author":"Barbonetti","year":"2018","journal-title":"J Endocrinol Invest."},{"key":"B3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/andr.12502","article-title":"European academy of andrology guideline management of oligo-astheno-teratozoospermia","volume":"6","author":"Colpi","year":"2018","journal-title":"Andrology."},{"key":"B4","first-page":"169","article-title":"Diseases of the hypothalamus and the pituitary gland","volume-title":"Andrology. Male Reproductive Health and Dysfunction.","author":"Behre","year":"2010"},{"key":"B5","first-page":"437","article-title":"Testosterone therapy","volume-title":"Andrology. Male Reproductive Health and Dysfunction.","author":"Nieschlag","year":"2010"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e46682","DOI":"10.1371\/journal.pone.0046682","article-title":"LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling","volume":"7","author":"Casarini","year":"2012","journal-title":"PLoS ONE."},{"key":"B7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1210\/er.2018-00116","article-title":"Clinical management of congenital hypogonadotropic hypogonadism","volume":"40","author":"Young","year":"2019","journal-title":"Endocr Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1530\/eje.0.1390298","article-title":"Pulsatile GnRH or human chorionic gonadotropin\/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases","volume":"139","author":"B\u00fcchter","year":"1998","journal-title":"Eur J Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4103\/1008-682X.193568","article-title":"Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism","volume":"19","author":"Mao","year":"2017","journal-title":"Asian J Androl."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/S0140-6736(64)91212-7","article-title":"Restoration of human spermatogenesis by menopausal gonadotrophins","volume":"1","author":"Macleod","year":"1964","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0015-0282(16)35821-6","article-title":"The restoration of human spermatogenesis and of the reproductive tract with urinary gonadotropins following hypophysectomy","volume":"17","author":"MacLeod","year":"1966","journal-title":"Fertil Steril."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/S0015-0282(16)57619-5","article-title":"Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male","volume":"63","author":"Kliesch","year":"1995","journal-title":"Fertil Steril."},{"key":"B13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/j.1939-4640.2003.tb02712.x","article-title":"Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone","volume":"24","author":"Bouloux","year":"2003","journal-title":"J Androl."},{"key":"B14","first-page":"217","article-title":"D\u00b7I\u00b7R annual 2017 \u2013 the German IVF-registry","volume":"15","author":"Blumenauer","year":"2018","journal-title":"J Reproduktionsmed Endrokrinol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/andr.12128","article-title":"Causes of hypogonadotropic hypogonadism predict response to gonadotropin substitution in adults","volume":"4","author":"Rohayem","year":"2016","journal-title":"Andrology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1210\/jcem-66-6-1144","article-title":"Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size","volume":"66","author":"Burris","year":"1988","journal-title":"J Clin Endocrinol Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1097\/01.ju.0000158133.09197.f4","article-title":"Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study","volume":"173","author":"Miyagawa","year":"2005","journal-title":"J Urol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1210\/jc.2008-1648","article-title":"Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome","volume":"94","author":"Liu","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.fertnstert.2008.07.1720","article-title":"A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin","volume":"92","author":"Warne","year":"2009","journal-title":"Fertil Steril."},{"key":"B20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.beem.2014.10.005","article-title":"Gonadotrophin replacement for induction of fertility in hypogonadal men","volume":"29","author":"Dwyer","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e2867","DOI":"10.1097\/MD.0000000000002867","article-title":"Efficacy and outcome predictors of gonadotropin treatment for male congenital hypogonadotropic hypogonadism: a retrospective study of 223 patients","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine."},{"key":"B22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0015-0282(98)00156-3","article-title":"Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group","volume":"70","year":"1998","journal-title":"Fertil Steril."},{"key":"B23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0015-0282(01)02973-9","article-title":"Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism","volume":"77","author":"Bouloux","year":"2002","journal-title":"Fertil Steril."},{"key":"B24","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/BF03346659","article-title":"Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism","volume":"33","author":"Sinisi","year":"2010","journal-title":"J Endocrinol Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12958-017-0232-y","article-title":"An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism","volume":"15","author":"Nieschlag","year":"2017","journal-title":"Reprod Biol Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.6061\/clinics\/2013(Sup01)09","article-title":"Hypogonadotropic hypogonadism revisited","volume":"68","author":"Fraietta","year":"2013","journal-title":"Clinics."},{"key":"B27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11255-011-0065-0","article-title":"Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience","volume":"44","author":"Yang","year":"2012","journal-title":"Int Urol Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1530\/eje.0.1470617","article-title":"Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone","volume":"147","author":"Depenbusch","year":"2002","journal-title":"Eur J Endocrinol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1210\/jc.2014-3802","article-title":"Sequential versus continual purified urinary FSH\/hCG in men with idiopathic hypogonadotropic hypogonadism","volume":"100","author":"Zhang","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"B30","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1210\/er.2018-00065","article-title":"Two hormones for one receptor: evolution, biochemistry, actions, and pathophysiology of LH and hCG","volume":"39","author":"Casarini","year":"2018","journal-title":"Endocr Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1365-2605.1982.tb00278.x","article-title":"Combined hMG\/hCG treatment in subfertile men with idiopathic normogonadotrophic oligozoospermia","volume":"5","author":"Schill","year":"1982","journal-title":"Int J Androl."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1210\/jcem-65-6-1081","article-title":"Treatment of severe oligospermia with human chorionic gonadotropin\/human menopausal gonadotropin: a placebo-controlled, double blind trial","volume":"65","author":"Knuth","year":"1987","journal-title":"J Clin Endocrinol Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/humrep\/13.3.596","article-title":"Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial","volume":"13","author":"Kamischke","year":"1998","journal-title":"Hum Reprod."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1093\/humrep\/dew167","article-title":"Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study","volume":"31","author":"Simoni","year":"2016","journal-title":"Hum Reprod."},{"key":"B35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/andr.12333","article-title":"Short-term FSH treatment and sperm maturation: a prospective study in idiopathic infertile men","volume":"5","author":"Casamonti","year":"2017","journal-title":"Andrology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3389\/fendo.2018.00734","article-title":"Effects of FSH on sperm DNA fragmentation: review of clinical studies and possible mechanisms of action","volume":"9","author":"Muratori","year":"2018","journal-title":"Front Endocrinol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.rbmo.2018.06.023","article-title":"Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management - meta-analyses","volume":"37","author":"Santi","year":"2018","journal-title":"Reprod Biomed Online."},{"key":"B38","volume-title":"WHO Laboratory Manual for the Examination and Processing of Human Semen.","year":"2010"},{"key":"B39","doi-asserted-by":"publisher","first-page":"CD005071","DOI":"10.1002\/14651858.CD005071.pub4","article-title":"Gonadotrophins for idiopathic male factor subfertility","author":"Attia","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"R46","DOI":"10.1530\/EC-15-0050","article-title":"FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis","volume":"4","author":"Santi","year":"2015","journal-title":"Endocr Connect."},{"key":"B41","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/cen.12770","article-title":"Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population","volume":"83","author":"Ding","year":"2015","journal-title":"Clin Endocrinol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.fpc.0000167330.92786.5e","article-title":"Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation","volume":"15","author":"Behre","year":"2005","journal-title":"Pharmacogenet Genomics."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.fertnstert.2011.09.034","article-title":"Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter","volume":"96","author":"Ferlin","year":"2011","journal-title":"Fertil Steril."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1111\/j.1365-2605.2010.01134.x","article-title":"Effects of endogenous FSH on normal human spermatogenesis in adults","volume":"34","author":"Selice","year":"2011","journal-title":"Int J Androl."},{"key":"B45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fendo.2019.00047","article-title":"Pharmacogenetics of FSH action in the male","volume":"10","author":"Schubert","year":"2019","journal-title":"Front Endocrinol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e12665","DOI":"10.1111\/and.12665","article-title":"Pregnancy after intracytoplasmic sperm injection following extended sperm preparation and hormone therapy in an azoospermic man with maturation arrest and microlithiasis: a case report and literature review","volume":"49","author":"Barbotin","year":"2017","journal-title":"Andrologia."},{"key":"B47","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5301\/uj.5000253","article-title":"Effectiveness of highly purified urofollitropin treatment in patients with idiopathic azoospermia before testicular sperm extraction","volume":"85","author":"Cocci","year":"2018","journal-title":"Urologia."},{"key":"B48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11255-019-02091-8","article-title":"Hormonal stimulation of spermatogenesis: a new way to treat the infertile male with non-obstructive azoospermia?","volume":"51","author":"Laursen","year":"2019","journal-title":"Int Urol Nephrol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.3238\/arztebl.2018.Rili","article-title":"Richtlinie zur Entnahme und \u00dcbertragung von menschlichen Keimzellen im Rahmen der assistierten Reproduktion","year":"2018","journal-title":"Deutsches \u00c4rzteblatt."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00322\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:43:29Z","timestamp":1558687409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00322\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":49,"alternative-id":["10.3389\/fendo.2019.00322"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00322","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]},"article-number":"322"}}